Skip to main content
. 2017 Dec 22;7(1):270–281. doi: 10.1002/cam4.1166

Figure 4.

Figure 4

Event‐free survival in patients with aggressive B‐cell lymphoma according to 25(OH)D levels at diagnosis. (A) Group A (n = 50 patients) had 25(OH)D levels ≥ 20 ng/mL at diagnosis, group B (n = 104 patients) had 25(OH)D levels <20 ng/mL at diagnosis. The survival difference is statistically significant (P = 0.01). (B) The survival analysis was restricted to 116 patients treated with R‐CHOP containing full dose of doxorubicin, according to 25(OH)D levels. Group A (n = 43 patients) had 25(OH)D levels ≥20 ng/mL at diagnosis, group B (n = 73 patients) had 25(OH)D levels <20 ng/mL at diagnosis. The difference is statistically significant (P = 0.03).